Other News To Note
Tuesday, October 2, 2012
AvidBiotics Corp., of South San Francisco, said it received a two-year, $600,000 grant from the National Institute of Allergy and Infectious Diseases to further develop its targetable bactericidal proteins against Clostridium difficile bacteria.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.